BioTech gives life to central NJ office market

TRD New York /
Feb.February 01, 2012 10:00 AM

After a brief recession-related hiccup, a highly coveted life science cluster is continuing to grow in central New Jersey, according to the New York Times.

While proximity to major research universities helped build the established biotechnology clusters in Boston and Durham, N.C., central Jersey’s access to major transportation and distribution systems — Route 1, the New Jersey Turnpike and Route 130 — have given birth to biotech in the Garden State. The industry is highly coveted by many municipalities, including New York City, for the stable, high-paying jobs it provides.

Johnson & Johnson, Merck, Bristol-Meyers Squibb and ImClone Systems already occupy some of the area’s 6.5 million square feet of lab space (about 5 percent of total office space) and 2.5 million square feet of research and development space. Excepting the six-building, 311,000-square-foot Technology Centre of New Jersey in New Brunswick, all of the development has been done privately.

Now much more development is underway.

For example, In East Windsor, developer Woodmont Properties is erecting SciPark, a planned four building complex of approximately a quarter-million square feet, where the first structure will open in March for chemical company Elementis P.L.C. Moreover, Princeton is conducting a $215 million redevelopment of a 770,000-square-foot building in its Princeton Forrestal Center. [NYT]


Related Articles

arrow_forward_ios
(Image by Wolfgang & Hite via Dezeen)

Hudson Yards megadevelopment inspires a new line of sex toys

Hudson Yards megadevelopment inspires a new line of sex toys
Cammeby's International Group founder Rubin Schron and, from top: 194-05 67th Avenue, 189-15 73rd Avenue and 64-05 186th Lane (Credit: Google Maps)

Ruby Schron lands $500M refi for sprawling Queens apartment portfolio

Ruby Schron lands $500M refi for sprawling Queens apartment portfolio
Wendy Silverstein (Credit: Getty Images)

Wendy Silverstein, co-head of WeWork’s real-estate fund, is out

Wendy Silverstein, co-head of WeWork’s real-estate fund, is out
From left: G.H. Palmer's Geoffrey Palme, RFR Holdings' Aby Rosen, Macklowe Properties' Harry Macklowe, Thor Equities' Joseph Sitt and Ellicott Development's Carl Paladino (Getty, iStock)

Harry Macklowe, Aby Rosen and Joe Sitt among 6,500+ developers, landlords who got PPP bucks

Harry Macklowe, Aby Rosen and Joe Sitt among 6,500+ developers, landlords who got PPP bucks
From left: SL Green CEO Marc Holliday, Ceruzzi Properties’ Arthur Hooper, the Lipstick Building at 885 Third Avenue and IRSA president Eduardo Elsztain (Getty, Wikipedia, Google Maps)

Lipstick Building ground rent reset leads to appraisal dispute

Lipstick Building ground rent reset leads to appraisal dispute
Knotel CEO Amol Sarva (Sasha Maslov, iStock)

Knotel’s Q2 revenue plunged 20%

Knotel’s Q2 revenue plunged 20%
Heirs unapparent: How RE firms plan — or don’t — for futures without the founder

Heirs unapparent: How RE firms plan — or don’t — for futures without the founder

Heirs unapparent: How RE firms plan — or don’t — for futures without the founder
Ziel Feldman (iStock)

HFZ Capital launches new fund for REIT investing

HFZ Capital launches new fund for REIT investing
arrow_forward_ios

The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

Loading...